Research programme: Small molecule therapeutics - AGV Discovery
Alternative Names: AGV06 programme for small molecules - AGV DiscoveryLatest Information Update: 17 Apr 2023
At a glance
- Originator AGV Discovery
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 05 Apr 2023 Early research in Cancer in France (unspecified route) prior to April 2023 (AGV Discovery pipeline, April 2023)